Skip to main content
OpenTrials
Completed

NCT Number: NCT05616767

Prevention and Screening for Early Detection of HPV-related Cancers in Gay and Bisexual Men in Tanzania

The long-term objective of the parent study is "to reduce the effects of OPCa through secondary prevention (i.e., early detection, diagnosis and treatment referral)." Consistent with this, this supplement will test HPV-related interventions tailored for Sexual Minority Men (SMM). Acceptability, feasibility and preliminary effectiveness of a smart-phone delivered Oropharyngeal Cancer (OPCA) self-assessment tool will be assessed. Given that homosexuality is stigmatized and criminalized in Tanzania, and that cell phone use is the key way SMM communicate in Tanzania, a self-assessment screening cell phone intervention holds particular promise for SMM in Tanzania but warrants separate evaluation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HPV

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Dar es Salaam

Dar es Salaam, Tanzania

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age over 18
  • gay or bisexual men
  • speak Kiswahili or English
  • resident in Dar es Salam

Treatment and study plan

Training on self-screening and HPV vaccination administration

Other

Participants will be taught how to do self-screening for HPV-associated cancers using Training on self-screening and HPV vaccination administration. They will also be given HPV vaccination series.

Primary outcomes

  1. assess screening practices of hrHPV-related OPCa

    Time frame: Baseline

    Questionaire

  2. To assess the acceptability and feasibility of teaching SMM in Tanzania to conduct self-exams

    Time frame: baseline to 6 months

    Questionaire to assess post-test selfie evaluations, Scores: 0= was not trained; 1= was trained; 2=took a selfie; 3= clear selfie

  3. To assess the acceptability and feasibility of hrHPV vaccination

    Time frame: baseline

    percentage of individuals recruited for aim 1 who request HPV vaccination, Scores are 0=no vaccination; 1=first vaccination; 2= second vaccination; 3=third vaccination

  4. To assess the acceptability and feasibility of hrHPV vaccination

    Time frame: 1 month

    percentage of individuals recruited for aim 1 who request HPV vaccination, Scores are 0=no vaccination; 1=first vaccination; 2= second vaccination; 3=third vaccination

  5. To assess the acceptability and feasibility of hrHPV vaccination

    Time frame: 6 months

    percentage of individuals recruited for aim 1 who request HPV vaccination, Scores are 0=no vaccination; 1=first vaccination; 2= second vaccination; 3=third vaccination

Sponsors and collaborators

Lead sponsor

University of Minnesota

Other

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Nov 15, 2022
Registry last updated
Dec 14, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.